Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over

Figure 3 Sustained virological response rates according to background factors. Although no significant differences are seen in comparisons of sustained virological response rates according to sex, cirrhosis, elderly cirrhosis, interferon plus ribavirin therapy, anemia (hemoglobin < 12 g/dL), or chronic kidney disease (estimated glomerular filtration rate < 60 mL/min/1.73 m²), a significant difference is evident between patients with and without a history of hepatocellular carcinoma treatment (P = 0.004). CKD: Chronic kidney disease; eGFR: Estimated glomerular filtration rate; Hb: Hemoglobin; HCC: Hepatocellular carcinoma.